Skip to content

Strategies to reduce the social gradient in bowel cancer screening: the ASCEND project

Strategies to reduce the social gradient in bowel cancer screening: the ASCEND project

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74121020
Enrollment
42000
Registered
2012-10-17
Start date
2012-11-05
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer Cancer Malignant neoplasm of rectosigmoid junction

Interventions

All of the interventions listed below will be tested against usual practice in Bowel Cancer Screening Programme. 1. Gist intervention: This is an information leaflet which offers two levels of infor

Sponsors

University College London (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men and women eligible to be screened for bowel cancer in England 2. Aged between 60-74 years

Exclusion criteria

Exclusion criteria: In Intervention 3 (GP endorsed invitation letters) we will only be able to randomise eligible people to receive this intervention if they are registered with practices that have agreed to endorse the BCSP. We estimate that only about 30% of all GP practices in England will consent to their name being used on BCSP invitation letters so the majority of eligible people will receive the usual invitation letters.

Design outcomes

Primary

MeasureTime frame
The proportion of people in each socioeconomic group returning an adequate faecal occult blood test (FOBt) within 18 weeks of being sent an invitation. Socioeconomic groups will be identified using Index of Multiple Deprivation (IMD) quintile scores

Secondary

MeasureTime frame
1. Time taken to return FOBt by IMD quintile 2. Proportion of spoilt kits and their relationship to IMD quintile 3. Proportion of non-delivered kits by IMD quintile 4. Incremental cost per screening invitation 5. Incremental cost per screening invitation, both by IMD quintile and overall 6. All of the above outcomes analysed using other socioeconomic variables

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026